Position in PBYI
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$190,287
+$28,858 QoQ
Shares Held
29,779
+9.8% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PBYI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Kathmere Capital Management, LLC holds $1,009,558 across 7 Biotechnology names. PBYI ranks #3 (18.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SXTP |
60 Degrees Pharmaceuticals, Inc.
|
144,683 | $253,195 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
489 | $218,358 | |
| 3 | PBYI |
Puma Biotechnology, Inc.
This page
|
29,779 | $190,287 | |
| 4 | AUPH |
Aurinia Pharmaceuticals Inc.
|
11,243 | $166,621 | |
| 5 | ARTL |
Artelo Biosciences, Inc.
|
13,250 | $100,435 | |
| 6 | ORMP |
Oramed Pharmaceuticals Inc.
|
15,071 | $51,241 | |
| 7 | BDTX |
Black Diamond Therapeutics, Inc.
|
13,813 | $29,421 |
All Filings in PBYI
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $190,287 | 29,779 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $161,429 | 27,131 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $148,430 | 27,953 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $69,299 | 20,204 | Shares | Sole | 2025-07-16 | |
| No filing history on record for this holder in this stock. | ||||||